Submitted by Anonymous (not verified) on 10 April 2026 - 9:20
Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 13, Status: Authorised
Source: